Using Real-World Data To Optimize Your Next Oncology Trial Protocol, ft. BMS

Set your trial up for operational and scientific success.

Clinical trials serve as the linchpin in bringing innovative cancer treatments to market. However, modern trials can be complex, expensive, prone to delays, and their success is far from guaranteed. Thankfully, trial sponsors and contract research organizations (CROs) can now draw on high-quality real-world data (RWD) at the protocol design stage to anticipate potential problems and address them before they become costly and time-consuming. In this playbook, clinical research experts from Bristol Myers Squibb and Flatiron Health unpack the current challenges facing clinical trials and provide a four-step guide to help the various roles involved in clinical trial design maximize the impact of RWD on future trials. We explore:

• RWD’s current usage
• Case studies demonstrating the real impact of RWD on protocol design
• Steps to maximize use of RWD in your organization
• Key updates from the FDA
• And more